๐งช
News
Decentralized Clinical Trials Enable 89% Remote Participation: Virtual Visits Reduce Patient Burden by 67% While Expanding Access
DCT platforms combining telemedicine, wearable monitoring, and direct-to-patient drug delivery are revolutionizing trial accessibility, reducing patient travel burden from 12 visits to 4 in-person visits while accelerating enrollment by 285% and improving retention to 94%.